Birch Hill Investment Advisors buys $35,999,849 stake in Zimmer Biomet Holdings Inc (ZBH)

Zimmer Biomet Holdings Inc (ZBH) : Birch Hill Investment Advisors scooped up 6,012 additional shares in Zimmer Biomet Holdings Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 12, 2016. The investment management firm now holds a total of 278,335 shares of Zimmer Biomet Holdings Inc which is valued at $35,999,849.Zimmer Biomet Holdings Inc makes up approximately 3.34% of Birch Hill Investment Advisors’s portfolio.

Other Hedge Funds, Including , Formidable Asset Management sold out all of its stake in ZBH during the most recent quarter. The investment firm sold 287 shares of ZBH which is valued $37,121.Blackrock Investment Management boosted its stake in ZBH in the latest quarter, The investment management firm added 123,898 additional shares and now holds a total of 1,081,887 shares of Zimmer Biomet Holdings Inc which is valued at $139,931,265. Zimmer Biomet Holdings Inc makes up approx 0.17% of Blackrock Investment Management’s portfolio.Rothschild Asset Management Inc boosted its stake in ZBH in the latest quarter, The investment management firm added 337 additional shares and now holds a total of 6,922 shares of Zimmer Biomet Holdings Inc which is valued at $902,836. Zimmer Biomet Holdings Inc makes up approx 0.02% of Rothschild Asset Management Inc’s portfolio.

Zimmer Biomet Holdings Inc opened for trading at $129.71 and hit $130.96 on the upside on Monday, eventually ending the session at $130.59, with a gain of 0.83% or 1.08 points. The heightened volatility saw the trading volume jump to 8,56,928 shares. Company has a market cap of $26,120 M.

On the company’s financial health, Zimmer Biomet Holdings Inc reported $2.02 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $1.97. The company had revenue of $1934.00 million for the quarter, compared to analysts expectations of $1898.18 million. The company’s revenue was up 65.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.58 EPS.

Many Wall Street Analysts have commented on Zimmer Biomet Holdings Inc. SunTrust Initiated Zimmer Biomet Holdings Inc on Aug 11, 2016 to “Buy”, Price Target of the shares are set at $155.Company shares were Reiterated by Needham on Jul 29, 2016 to “Buy”, Firm has raised the Price Target to $ 150 from a previous price target of $143 .Company shares were Reiterated by Needham on Jul 18, 2016 to “Buy”, Firm has raised the Price Target to $ 143 from a previous price target of $134 .

Zimmer Biomet Holdings Inc. formerly Zimmer Holdings Inc. is a musculoskeletal healthcare company. The Company designs manufactures and markets orthopedic reconstructive products; sports medicine biologics extremities and trauma products; spine bone healing craniomaxillofacial and thoracic products; dental implants and related surgical products. The Company manages its operations through three geographic segments: the Americas comprising principally of the United States and includes other North Central and South American markets; Europe comprising principally of Europe and includes the Middle East and African markets; and Asia Pacific comprising primarily of Japan and includes other Asian and Pacific markets. The Company markets and sells products through three channels: direct to healthcare institutions such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers and directly to dental practices and dental laboratories.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *